| Patents for C07C 311 - Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups (17,647) |
|---|
| 05/27/2004 | US20040102491 Antimicrobial agents |
| 05/27/2004 | US20040102418 Compounds for the treatment of inflammatory disorders |
| 05/27/2004 | US20040102313 Comprises rhodium/ruthenium/iridium complexes with sulfonated bidentate ligands (diamines) |
| 05/27/2004 | CA2505098A1 Phenylcarboxamide beta-secretase inhibitors for the treatment of alzheimer's disease |
| 05/26/2004 | EP1421066A1 Sulfonylamino derivatives useful as herbicides |
| 05/26/2004 | EP1421057A1 Chemotherapeutic agents |
| 05/26/2004 | EP1421056A1 (alpha)-haloenamine reagents |
| 05/26/2004 | EP1206446B1 Carboxylic acid amides, their production and their use as drugs |
| 05/26/2004 | EP1005445B1 N-alkanoylphenylalanine derivatives |
| 05/26/2004 | CN1500075A Perfluorovinyl ether monomer having sulfonamide group |
| 05/26/2004 | CN1499928A Alkylamine derivatives as antifouling agents |
| 05/25/2004 | CA2048172C Substituted sulfonamids, preparation processes and drugs containing same |
| 05/21/2004 | WO2004041264A1 2-oxo-ethanesulfonamide derivates |
| 05/21/2004 | WO2003086605A3 Functionalized ionic liquids, and methods of use thereof |
| 05/20/2004 | US20040097757 Method for fluorinating a compound comprising a halosulphonyl or dihalophosphonyl group |
| 05/20/2004 | US20040097755 Ionic liquids and their use as solvents |
| 05/20/2004 | US20040097594 Sulfonamide inhibitors of aspartyl protease |
| 05/20/2004 | US20040097589 Thyroid receptor ligands, pharmaceutical compositions comprising them and their use in the treatment of disorders influenced by thyroid hormones |
| 05/20/2004 | US20040097572 For Alzheimer's Disease and other conditions characterized by aberrant extracellular deposition of amyloid, for therapy of Down's Syndrome |
| 05/20/2004 | US20040097561 Benzamides and related inhibitors of factor Xa |
| 05/20/2004 | US20040097547 For therapy of chemokine-mediated diseases such as acute and chronic inflammatory disorders and cancer |
| 05/20/2004 | US20040097499 Useful for potentiating glutamate receptor function in a mammal and therefore, useful for treating a wide variety of conditions, such as psychiatric and neurological disorders |
| 05/20/2004 | US20040097407 Method for the synthesis of compounds of formula I and their uses thereof |
| 05/20/2004 | US20040097375 Substituted fluoroalcoxyphenylsulfonylurea |
| 05/19/2004 | EP1420011A1 Compounds usefulfor treating allergic and inflammatory diseases |
| 05/19/2004 | EP1419126A1 Fluorous nucleophilic substitution of alcohols and reagents for use therein |
| 05/19/2004 | EP1418950A1 Solid-phase nucleophilic fluorination |
| 05/19/2004 | EP1286961B1 Sulfonated perfluorovinyl functional monomers |
| 05/19/2004 | CN1498205A Aryl and biaryl compounds having MCH modulatory activity |
| 05/19/2004 | CN1149987C Pharmaceutical composition comprising combination of dextro-and laevo-isomers of sotalol |
| 05/13/2004 | WO2004039762A1 Phenethanolamine derivatives for the treatment of respiratory diseases |
| 05/13/2004 | WO2004039753A2 Phenyl compounds |
| 05/13/2004 | WO2003006652A3 Inhibition of specific histone deacetylase isoforms |
| 05/13/2004 | US20040092770 Alpha-haloenamine reagents |
| 05/13/2004 | US20040092517 Phenyl derivatives and their use in the treatment of thromboembolic disorders or tumours |
| 05/13/2004 | US20040092505 Substituted aminoalkylamide derivatives as antagonists of follicle stimulating hormone |
| 05/13/2004 | US20040092490 Substituted tetracycline compounds for the treatment of malaria |
| 05/13/2004 | US20040092401 Plant safening agents |
| 05/13/2004 | US20040091951 Assay for measuring acetylation or deacetylation activity of an enzyme |
| 05/12/2004 | EP1417169A2 Selective estrogen receptor modulators |
| 05/12/2004 | EP1317178B1 Fungicidal compositions |
| 05/12/2004 | CN1496355A Substituted fluoroalcoxyphenylsulfonylurea |
| 05/12/2004 | CN1496346A Novel colour former and recording material |
| 05/12/2004 | CN1495160A I-substituted-1-aminomethyl-cycloalkane derivative (gabapentin analogs), its preparation and application for curing neuropathy |
| 05/12/2004 | CN1149188C Arylaminomethylenecamphor derivatives |
| 05/11/2004 | US6734203 Fused imidazolium derivatives |
| 05/11/2004 | US6734186 Phosphodiesterase 2 inhibitor |
| 05/11/2004 | US6734182 Aryl sulfonamides and sulfamide derivatives and uses thereof |
| 05/06/2004 | WO2003106428A8 Arylsulphonamide derivatives and use thereof as b1 bradykinin receptor antagonists |
| 05/06/2004 | WO2003051894A8 Preparation of ionic liquids |
| 05/06/2004 | WO2003040096A3 N, n'-substituted-1,3-diamino-2-hydroxypropane derivatives |
| 05/06/2004 | US20040087798 Novel amide compounds |
| 05/06/2004 | US20040087650 Inhibitors of IMPDH enzyme |
| 05/06/2004 | US20040087620 Terphenyl compounds bearing substituted amino groups |
| 05/06/2004 | EP1415984A1 Aryloxyarylsulfonylamino hydroxamic acid derivatives |
| 05/06/2004 | EP1415983A1 5-amidino-n-(2-aminophenethyl)-hydroxybenzenesulfonamide derivative, medicinal composition containing the same, and intermediate therefor |
| 05/06/2004 | EP1414801A1 Arylamines for the treatment of conditions associated with gsk-3 |
| 05/06/2004 | EP1414790A1 Substituted n-acyl aniline derivatives, production and use thereof as medicaments |
| 05/06/2004 | EP1414788A1 Naphthylurea and naphthylacetamide derivatives as vanilloid receptor 1 (vr1) antagonists |
| 05/05/2004 | CN1494532A New asymmetric process for preparation of diarylmethylpiperazines derivatives and novel asymmetric diarylmetylamines as intermediates |
| 05/05/2004 | CN1494528A Benzophenones as inhibitors of reverse transcriptase |
| 05/04/2004 | US6730783 Reacting aminoguanidine with carbonyl compound to form amidinohydrazone; reduction; reacting with alkoxyamine; guanidinylation; anticoagulants |
| 05/04/2004 | US6730704 1-(aryloxy)propionoyl-2-arylsulfonyl hydrazines, process for preparation thereof and use thereof as hypoglycemic agents |
| 05/04/2004 | US6730671 Compounds useful as reversible inhibitors of cathespin S |
| 04/29/2004 | WO2004035533A1 Novel n-hydroxy thiourea, urea and amide compounds and the pharmaceutical compositions comprising the same |
| 04/29/2004 | WO2004034999A2 Nitrone compounds, pharmaceutical compositions containing the same and methods for treating inflammation and neuropathic pain |
| 04/29/2004 | WO2004016221A3 Sulfonamides as potassium channel blockers |
| 04/29/2004 | WO2003009807A3 Cytoprotective compounds, pharmaceutical and cosmetic formulations, and methods |
| 04/29/2004 | US20040082652 Nitric ester derivatives and their use in treating gastrointestinal tumors |
| 04/29/2004 | US20040082630 1g(a)-Amino-n-hydroxy-acetamide derivatives |
| 04/29/2004 | US20040082628 Acylated arylcycloalkylamines and their use as pharmaceuticals |
| 04/29/2004 | US20040082625 Osteoporosis, bone disorders |
| 04/29/2004 | US20040082601 Anti-inflammatory compounds |
| 04/29/2004 | US20040082553 Novel florfenicol-type antibiotics |
| 04/29/2004 | US20040082550 Tropolone derivative |
| 04/29/2004 | US20040082548 Cardiovascular disorders; Alzheimer's disease; anticholesterol agents |
| 04/29/2004 | US20040082499 Perturbed membrane-binding compounds |
| 04/29/2004 | CA2502527A1 Novel n-hydroxy thiourea, urea and amide compounds and the pharmaceutical compositions comprising the same |
| 04/29/2004 | CA2502227A1 Nitrone compounds, pharmaceutical compositions containing the same and methods for treating inflammation and neuropathic pain |
| 04/28/2004 | EP1414088A1 Novel onium salt, electrolyte for nonaqueous cell containing the novel onium salt for nonaqueous cell, and method for optimizing negative electrode using electrolyte containing onium salt |
| 04/28/2004 | EP1051394B1 Potassium channel inhibitors |
| 04/28/2004 | EP1003718B1 Method for the production of n-(5-amino-2-cyano-4-fluoro-phenyl)-sulphonamides |
| 04/28/2004 | CN1492854A Water-and oil-repellency imparting ester oligomers comprising perfluoroalkyl moieties |
| 04/28/2004 | CN1147294C Pentafluorobenzenesulfonamides and analogs |
| 04/27/2004 | US6727386 Heating one or more aromatic compounds in presence of a first reactant so as to form one or more product compounds containing aromatic-sulfonimide or aromatic-methylidynetrissulfonyl bonds |
| 04/27/2004 | US6727282 Human immunodeficiency virus (hiv) or aids treatment |
| 04/27/2004 | US6727250 Administering compounds such as trans-3-(naphth-2-yl)-but-2-enoic acid-n-(2-carboxy-phenyl)-amide or like for therapy of conditions associated with increased telomerase activity, e.g. tumour diseases |
| 04/22/2004 | WO2004033422A2 Modulation of anxiety through blockade of anandamide hydrolysis |
| 04/22/2004 | WO2004033419A1 Sulfonamides having antiangiogenic and anticancer activity |
| 04/22/2004 | WO2004033418A2 Sulfonylamino-acetic derivatives and their use as orexin receptor antagonists |
| 04/22/2004 | WO2004033415A1 Nitroaniline-based alkylating agents and their use as prodrugs |
| 04/22/2004 | WO2004013077A3 Cyclopentanone and cyclopentanone derivatives as potent activators of hsf-1 |
| 04/22/2004 | WO2000061134A9 Antimicrobial agents |
| 04/22/2004 | US20040077861 Asymmetric addition of organometallic compounds to chiral sulfinimine to give adducts in predominantly one diastereomer can subsequently be transferred into pure enantiomers of by cleavage of the chiral auxilliary |
| 04/22/2004 | US20040077726 Antiproliferative and anticarcinogenic agents; psoriasis |
| 04/22/2004 | US20040077694 Malonamic acids and derivatives thereof as thyroid receptor ligands |
| 04/22/2004 | US20040077691 Hydroxamate derivatives of non-steroidal anti-inflammatory drugs |
| 04/22/2004 | US20040076580 For diagnosis/treatment of thrombosis, embolism, atherosclerosis, inflammation or cancer; imaging |
| 04/22/2004 | CA2501520A1 Sulfonamides having antiangiogenic and anticancer activity |
| 04/22/2004 | CA2501506A1 Modulation of anxiety through blockade of anandamide hydrolysis |